Summit Therapeutics Inc.

NasdaqGM:SMMT Stock Report

Market Cap: US$2.3b

Summit Therapeutics Future Growth

Future criteria checks 0/6

Summit Therapeutics is forecast to grow revenue at 77.1% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth20.6%
Revenue growth rate77.1%
Future return on equityn/a
Analyst coverage

Low

Last updated25 Mar 2024

Recent future growth updates

No updates

Recent updates

Summit Therapeutics: A Strategic Analysis Of Ivonescimab's Progress

Jan 30

We're Hopeful That Summit Therapeutics (NASDAQ:SMMT) Will Use Its Cash Wisely

Dec 29
We're Hopeful That Summit Therapeutics (NASDAQ:SMMT) Will Use Its Cash Wisely

Summit Therapeutics slips on plans to terminate study for lead candidate

Oct 04

Summit Therapeutics: Developing Antibiotics Is A Noble Cause But The Company Is Wise To Expand Its Portfolio

Aug 17

Summit Therapeutics GAAP EPS of -$0.17, revenue of $0.23M

Aug 11

Summit to explore additional trial for its bacteria-induced colon infection drug

Jul 14

Here's Why We're Watching Summit Therapeutics' (NASDAQ:SMMT) Cash Burn Situation

Apr 29
Here's Why We're Watching Summit Therapeutics' (NASDAQ:SMMT) Cash Burn Situation

Summit Therapeutics - Disappointing Data But Not An Outright Failure

Dec 23

Summit Therapeutics: A Full Investment Analysis Of This Antibiotic Innovator

Jun 22

Summit Therapeutics to join Russell 3000 Index

Jun 08

Earnings and Revenue Growth Forecasts

NasdaqGM:SMMT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202610N/A-308-2491
12/31/2025N/AN/A-216-1721
12/31/2024N/AN/A-156-1201
12/31/2023N/A-615-552-77N/A
9/30/2023N/A-598-52-52N/A
6/30/20230-598-46-46N/A
3/31/20230-600-36-36N/A
12/31/20221-79-42-42N/A
9/30/20221-87-57-56N/A
6/30/20222-85-72-71N/A
3/31/20222-93-72-71N/A
12/31/20212-89-73-73N/A
9/30/20212-75-72-71N/A
6/30/20211-73-65-64N/A
3/31/20211-64-64-64N/A
12/31/20201-53-49-48N/A
9/30/20201-51-49-49N/A
6/30/20201-40-38-37N/A
3/31/2020-5-31-18-18N/A
12/31/20191-32-23-23N/A
10/31/201926-28-24-23N/A
7/31/201924-27-20-19N/A
4/30/20197212-24-24N/A
1/31/20195711-35-35N/A
10/31/2018702-36-36N/A
7/31/20187211-45-45N/A
4/30/201827-29-19-19N/A
1/31/201820-29-21-21N/A
10/31/201715-18N/A-20N/A
7/31/201712-23N/A31N/A
4/30/20175-27N/A14N/A
1/31/20173-27N/A15N/A
10/31/20161-29N/A15N/A
7/31/20161-33N/A-26N/A
4/30/20161-32N/A-29N/A
1/31/20162-29N/A-24N/A
10/31/20152-25N/A-23N/A
7/31/20153-20N/A-20N/A
4/30/20153-19N/A-21N/A
1/31/20153-17N/A-17N/A
10/31/20143-17N/A-16N/A
7/31/20144-17N/A-16N/A
4/30/20144-13N/A-11N/A
1/31/20143-10N/A-10N/A
10/31/20130-8N/A-6N/A
7/31/20132-6N/A-5N/A
4/30/20132-7N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SMMT's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if SMMT's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if SMMT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SMMT is forecast to have no revenue next year.

High Growth Revenue: SMMT is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SMMT's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.